Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.297
-0.004 (-1.46%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Mereo BioPharma Group Stock Forecast
MREO's stock price has decreased by -89.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Mereo BioPharma Group stock have an average target of 1.75, with a low estimate of 0.50 and a high estimate of 3.00. The average target predicts an increase of 490.02% from the current stock price of 0.30.
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Mereo BioPharma Group stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 2 | 1 | 1 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 12, 2026 |
| Needham | Needham | Buy Maintains $3 | Buy | Maintains | $3 | +911.46% | May 12, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3 | Buy | Maintains | $3 | +911.46% | May 12, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Mar 26, 2026 |
| BTIG | BTIG | Buy Maintains $1 | Buy | Maintains | $1 | +237.15% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
1.17M
from 500.00K
Increased by 133.67%
Revenue Next Year
19.48M
from 1.17M
Increased by 1,567.31%
EPS This Year
n/a
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.0M | 75.8M | |
| Avg | 1.2M | 19.5M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,302.0% | 6,390.2% | |
| Avg | 133.7% | 1,567.3% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.